drugset / Trial / NCT00185003

Blockade of Vascular Potassium Channels During Human Endotoxemia

NCT00185003

RandomizedParallel-groupOpen-labelTreatment

Summary

Background: Activation of NO-synthase and vascular potassium (K) channels may play a role in the sepsis-induced attenuated sensitivity to norepinephrine. We examined whether various K channel blockers and NO-synthase inhibition could restore norepinephrine sensitivity during experimental human endotoxemia.

Timeline

Start
2003-01
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject L-NMMA Unknown 0.2 unknown Other
Subject Quinin Unknown
Subject Tetraethylammonium Unknown Other
Subject Tolbutamide Small molecule

Indications

No indication recorded.